Epilepsy and paroxysmal conditions

Advanced search

Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy

Full Text:


Vestibular migraine is one of the most common causes of rotational vertigo, which, however, remains hard to diagnose a nosological entity. There will be discussed pathophysiological mechanisms and current therapeutic approaches along with epidemiology and diagnostic principles for vestibular migraine, which will be of value for hospital and out-patient neurologists as well as general practitioners.

About the Author

A. S. Bedenko
Sechenov University
Russian Federation

Bedenko Anna Sergeevna - neurologist, postgraduate student, RSCI SPIN-code: 1533-6140.

8-2 Trubetskaya Str., Moscow 119048


1. Tabeeva G.R., Azymova U.A. Zamergard M.V. The modern concept of vestibular migraine (discussion). Neurological journal. 2012; 17 (2): 45-53 (In Russ).

2. Strupp M., Dieterich M., Brandt T. The Treatment and Natural Course of Peripheral and Central Vertigo. Deutsches Arzteblatt International. 2013; 110 (29-30): 505-516.

3. Kathleen R., Merikangas PhD. Contributions of Epidemiology to Our Understanding of Migraine. Headache. 2013; 53 (2): 230-246.

4. Neuhauser H. K. Epidemiology of vertigo. Curr. Opin. Neurol. 2007: 20: 40-60.

5. Ayzenberg I., Katsarova Z., Mathalikov R., Chernysh M., Osipova V., Tabeeva G., Steiner T.J. The burden of headache in Russia: validation of diagnostic questionnaire in a population based simple. European journal of neurology. 2010; 18: 454-459. https ://

6. Bronstein A.M., Lempert T. Dizziness: A Practical Approuch to Diagnosis and Managment. Cambrige University Press; 2007; 83-91.

7. Bayazit Y., Yilmaz M., Mumbuc S., Kanlikama M. Assessment of migraine-related cochleovestibular symptoms. Revue Laryngol Otol Rhinol. 2001; 122: 85-88.

8. Gassieva D.M., Zamergrad M.V., Tabeeva G.R. Association between migraine and vestibular disorders. Epilepsy and paroxysmal conditions. 2019; 11 (1): 88-96. (In Russ.) https://

9. Furman J.M., Marcus D.A., Balaban C.D.Vestibular migraine: clinical aspects andpathophysiology. Lancet Neurol. 2013;12 (7): 706-715.

10. Chu C. H., Liu C.J., Lin L.Y., Chen T.J., Wang S.J. Migraine is associatedwith a increased risk for benign paroxysmal positional vertigo: anationwide population-based study. J Headache Pain. 2015; 16: 62.

11. Gopen Q., Viirre E., Anderson J: Epidemiologic study to explore linksbetween Meni'ere syndrome and migraine headache. Ear, Noseand Throat Journal. 2009; 88 (11): 1200-1204.

12. Radtke A., Neuhauser H., von Brevern M., Hottenrott T., Lempert T.Vestibular migraine validity of clinical diagnostic criteria at long-termfollow-up. J. Vestib. Res. 2010; 20: 207-208.

13. Cha Y. H., Lee H., Santell L. S., BalohR.W. Association of benignrecurrent vertigoand migraine in 208 patients. Cephalalgia. 2009; 29: 550-55.

14. The International Classification of Headache Disorders, 3rd edition. Cephalgia. 2018; 38 (1): 1-211.

15. Li A.V., Parchomenko E.V., Barinov A.N. Vestibular migraine: diagnosis and optimization of the therapy. Zhurnalnevrologiiipsi khiatriiimeni S.S. Korsakova (In Russ)

16. Maslovara S., Butkovi Soldo S., Paji-Penavi I., Alkhamis T., Vesligaj T., Soldo A. Vestibular migraine considering new diagnostic criteria. Neurol. Croat. 2014; 63: 1-2.

17. Gazquez I., Lopez-Escamez J. A. Genetics of recurrent vertigo and vestibular disorders. Curr Genomics. 2011; 12: 443-450.

18. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004 Jan 13. 62(1 ):17-22.

19. Neuhauser H.K., Radtke A. von Brevern M. et al. Migrainous vertigo: Prevalence and impact on quality of life. Neurology. 2006; 67: 1028-1033.

20. Bowyer S.M., Aurora K.S., Moran J. E. et al. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann. Neurol.2001; 50: 582-587.

21. Cavestro C., Ferrero M., Mandrino S., Di Tavi M., Rota E. Novelty in Inflammation and Immunomodulation in Migraine. Curr Pharm Des. 2019; 25 (27): 2919-2936.

22. Lempert T. Vestibular migraine. Seminars in neurology. 2013; 33 (3): 212-218.

23. Balaban C.D. Migraine, vertigo and migrainous vertigo: links between vestibular and pain mechanisms. Journal of vestibular research. 2011; 21 (6): 315-321.

24. Weiller C., May A., Limmroth V. et al. Brain stem activation in spontaneous human migraine attacks. Nat Med.1995; 1: 658-660.

25. Formeister E.R., Habib K., Jeffrey Michael S. The Epidemiology of Vestibular Migraine: A Population-based Survey Study. Otology & neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 2018; 39.

26. Lempert T., von Brevern M. Handbook of Clinical Neurology. 2016; 137: 301-316.

27. Neuhauser H., Radtke A., von Brevern M., Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebocontrolledtrial. Neurology. 2003; 60 (05): 882-883.

28. Prakash S., Shah N.D. Migrainous vertigo responsive to intravenous methylprednisolone: case reports. Headache. 2009; 49 (08): 1235-1239.

29. Bikhazi P., Jackson C., & Ruckenstein M.J. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. The American Journal of Otology. 1997; 18 (3): 350-354.

30. Perez, Angel J., Dinchen G., Theresa C., George.Topiramate for the Management of Vestibular Migraine. Otolaryngology - Head and Neck Surgery. 2013; 149: 238-238.

31. IvanovaT.A., GusevaA.L., Philatova E.G. Dizziness with migraine. Russian medical journal. 2017; 9: 602-606 (In Russ).

32. Stolte B., Holle В., Naegel S. Vestibular migraine. Cephalgia. 2014.

33. Lucetti C., Nuti A., Pavese N. et al. Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia.1998; 18: 349-352.

34. Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004; 2 (02): 103-108.

35. Liu F., Ma T., Che X., Wang Q., Yu S. The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibularmigraine. Front Neurol. 2017; 8: 524.

36. Qelebisoy N., Gokgay F., Karahan C. et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016; 273 (10): 2947-2951.

37. Cacciapuoti F. Migraine homocysteine-related: old and new mechanisms. Neurology and Clinical Neuroscience. 2017;

38. Song, Tae-Jin C., Min S., Jong-Hee A., Hong-Yup L., Sun C., Soo-Jin. Effect of Vitamin D Deficiency on the Frequency of Headaches in Migraine. Journal of Clinical Neurology. 2018; 14 (3): 366.

39. Isobe C., Terayama Y. A Remarkable Increase in Total Homocysteine Concentrations in the CSF of Migraine Patients With Aura. Headache. 2010; 50: 1561-1569.


For citations:

Bedenko A.S. Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy. Epilepsy and paroxysmal conditions. 2020;12(3):177-181. (In Russ.)

Views: 850

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)